Get started
Author

Angeline Ginzac

Observed names: A. Ginzac, A., Ginzac, Angeline Ginzac Couvé, Angeline Ginzac Couvé, Ginzac, Angeline
Observed institutions: Inserm, Université Clermont Auvergne, Centre Jean Perrin, Centre Hospitalier Universitaire de Clermont-Ferrand, Imagerie Moléculaire et Stratégies Théranostiques, Université de Clermont I
ORCID: 0000-0002-5614-0876
Observed ORCID: 0000-0002-5614-0876
OpenAlex ID: A5034202689
Multicenter randomized phase II study comparing docetaxel plus curcumin versus docetaxel plus placebo in first‐line treatment of metastatic castration‐resistant prostate cancer
2021 · Judith Passildas‐Jahanmohan, Jean‐Christophe Eymard, et al. · Cancer Medicine · 66
PDF
A decrease in brown adipose tissue activity is associated with weight gain during chemotherapy in early breast cancer patients
2020 · Angeline Ginzac, Bertrand Barres, et al. · BMC Cancer · 51
PDF
Artificial intelligence solution to classify pulmonary nodules on CT
2020 · D. Blanc, V. Racine, et al. · Diagnostic and Interventional Imaging · 45
PDF
Treatment-Induced Cardiotoxicity in Breast Cancer: A Review of the Interest of Practicing a Physical Activity
2019 · Angeline Ginzac, Judith Passildas, et al. · Oncology · 45
Predictive factors of toxicity of TPF induction chemotherapy for locally advanced head and neck cancers
2021 · Maureen Bernadach, Michel Lapeyre, et al. · BMC Cancer · 32
PDF
Exploring the concept of Total Pain in contemporary oncology palliative care: a qualitative study on patients' resources
2025 · Maya Corman, Michaël Dambrun, et al. · BMC Palliative Care · 27
Body Mass Index, Sarcopenia, and Their Variations in Predicting Outcomes for Patients Treated with Nivolumab for Metastatic Renal Cell Carcinoma
2021 · Tressie Herrmann, Cécile Mione, et al. · Oncology · 25
Eosinophil counts as a relevant prognostic marker for response to nivolumab in the management of renal cell carcinoma: a retrospective study
2021 · Tressie Herrmann, Angeline Ginzac, et al. · Cancer Medicine · 25
PDF
Impact of Chemotherapy-induced Menopause in Women of Childbearing Age With Non-metastatic Breast Cancer – Preliminary Results From the MENOCOR Study
2018 · Judith Passildas, Olivier Collard, et al. · Clinical Breast Cancer · 24
Continuous Wound Infiltration With Ropivacaine After Mastectomy: A Randomized Controlled Trial
2020 · Marie Beguinot, Emilie Monrigal, et al. · Journal of Surgical Research · 22
PDF
Sister Mary Joseph Nodules: A Case Report about a Rare Location of Skin Metastasis
2021 · Brice Leyrat, Maureen Bernadach, et al. · Case Reports in Oncology · 20
Weight Evolution During Endocrine Therapy for Breast Cancer in Postmenopausal Patients: Effect of Initial Fat Mass Percentage and Previous Adjuvant Treatments
2018 · Angeline Ginzac, Émilie Thivat, et al. · Clinical Breast Cancer · 17
Preoperative stereotactic radiosurgery for brain metastases: the STEP study protocol for a multicentre, prospective, phase-II trial
2021 · Angeline Ginzac, Guillaume Dupic, et al. · BMC Cancer · 16
PDF
Quality of life for older patients with cancer: a review of the evidence supporting melatonin use
2020 · Angeline Ginzac, Sophie Dubois, et al. · Aging Clinical and Experimental Research · 14
PDF
RFID trial: localization of non-palpable breast lesions using radiofrequency identification tags or wire
2023 · Hugo Veyssiere, Margot Dressaire, et al. · BMC Cancer · 10
PDF
Prospective Study on Body Composition, Energy Balance and Biological Factors Changes in Post-menopausal Women with Breast Cancer Receiving Adjuvant Chemotherapy Including Taxanes
2018 · Emilie Gadéa, Emilie Thivat, et al. · Nutrition and Cancer · 9
Neoadjuvant anthracycline-based (5-FEC) or anthracycline-free (docetaxel/carboplatin) chemotherapy plus trastuzumab and pertuzmab in HER2 + BC patients according to their TOP2A: a multicentre, open-label, non-randomized phase II trial
2024 · Angeline Ginzac, Ioana Molnar, et al. · Breast Cancer Research and Treatment · 7
PDF
Circulating tumour DNA in head and neck squamous-cell carcinomas: A literature review
2025 · Léo Ventelou, Angeline Ginzac, et al. · Cancer Treatment Reviews · 6
PDF
Patient satisfaction with radio-frequency identification (RFID) tag localization compared with wire localization for nonpalpable breast lesions: the RFID trial
2025 · Raphaël Pete, Céleste Pinard, et al. · BMC Cancer · 6
PDF
Preoperative stereotactic radiotherapy for the management of brain metastases
2024 · Julian Biau, Florent Guillemin, et al. · Cancer/Radiothérapie · 6
Pembrolizumab as a novel therapeutic option for patients with refractory thymic epithelial tumor: A case report
2021 · Jonathan Wong-Chong, Maureen Bernadach, et al. · World Journal of Clinical Cases · 6
A phase-II study based on dose adjustment according to UGT1A1 polymorphism: is irinotecan underdosed in first-line FOLFIRI regimen for mCRC?
2023 · Angeline Ginzac, Emilie Thivat, et al. · Cancer Chemotherapy and Pharmacology · 5
PDF
Prediction of residual disease using circulating DNA detection after potentiated radiotherapy for locally advanced head and neck cancer (NeckTAR): a study protocol for a prospective, multicentre trial
2023 · Angeline Ginzac, Marie-Céleste Ferreira, et al. · BMC Cancer · 4
PDF
Adapted Physical Activity for Breast Cancer Patients Treated with Neoadjuvant Chemotherapy and Trastuzumab Against HER2 (APACAN2): A Protocol for a Feasibility Study
2021 · Angeline Ginzac, Maureen Bernadach, et al. · Frontiers in Oncology · 4
PDF
XENOBREAST Trial: A prospective study of xenografts establishment from surgical specimens of patients with triple negative or luminal b breast cancer
2020 · Hugo Veyssière, Judith Passildas, et al. · F1000Research · 3
Works count: 49
Citation count: 498
H-index: 14
I10-index: 15
Year
Topic
Type